Prandin

Medicinal product

(Invented) name

Prandin

Active substance (s)

Repaglinidas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BX02, Repaglinide

Marketing authorisation holder

Novo Nordisk A/S, Danija

Date of authorisation

2001-01-29

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

tablet	1 vnt.
Repaglinidas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
27845	30387	1030387	lizdinė plokštelė	N30		Receptinis	EU/1/00/162/015	Netiekiama	-	-	No	-	-
27846	30388	1030388	lizdinė plokštelė	N90		Receptinis	EU/1/00/162/016	Netiekiama	-	-	No	-	-
27847	30389	1030389	lizdinė plokštelė	N120		Receptinis	EU/1/00/162/017	Netiekiama	-	-	No	-	-
27849	30391	1030391	lizdinė plokštelė	N270		Receptinis	EU/1/00/162/019	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2001-01-29	Registruotas